Outcomes
Measurable Impact Across Clinical and Financial Metrics
Every Prescient deployment is measured against the metrics your board, quality committee, and finance team already track — not a separate scorecard.
Clinical Metrics
What we measure clinically
Time to intervention
Elapsed time from risk-band change to documented clinical action.
In-hospital mortality
Tracked against each system's own pre-deployment baseline.
ICU transfer rate
Rate of unplanned escalation following a risk-band change.
Length of stay
Measured for patients flagged at High or Critical risk bands.
Clinical metrics — illustrative example
Illustrative example only, not a published result. Your deployment's actual numbers are measured against your own pre-deployment baseline — see Methodology below.
Financial Metrics
What we measure financially
Avoidable escalation cost
Cost associated with late-detected deterioration events.
Antibiotic utilization
Empiric therapy alignment with AMR resistance scoring.
Readmission rate
30-day readmission tracked for advanced-illness identified patients.
Financial metrics — illustrative example
Illustrative example only, not a published result.
Methodology
Every Result Is Benchmarked Against Your Own Baseline
Before go-live, Prescient establishes a pre-deployment baseline for each metric above using your system's own historical data. Post-deployment results are then measured against that same baseline — not an industry average — so the impact you see reflects your patients, your units, and your workflows.
A historical period long enough to account for seasonal and volume variation is agreed with your analytics team.
Clinical and financial metrics are matched to your existing quality and reporting structure, not a generic scorecard.
Post-deployment performance is reviewed on an ongoing cadence with your clinical and quality leadership.
Results Snapshots
From Deployments in Progress
Sepsis time-to-intervention
Tracking elapsed time from risk-band change to documented clinical action across an initial deployment cohort.
Advanced-illness readmission impact
Comparing 30-day readmission rates for the advanced-illness identified cohort against the pre-deployment baseline.
Frequently Asked